Omnizole
Brand names,
Omnizole
Analogs
Omnizole
Brand Names Mixture
Omnizole
Chemical_Formula
C11H16N2O
Omnizole
RX_link
http://www.rxlist.com/cgi/generic3/tocainide.htm
Omnizole
fda sheet
Omnizole
msds (material safety sheet)
Omnizole
Synthesis Reference
No information avaliable
Omnizole
Molecular Weight
192.258 g/mol
Omnizole
Melting Point
246-266 oC
Omnizole
H2O Solubility
1.07E+004 mg/L
Omnizole
State
Solid
Omnizole
LogP
1.308
Omnizole
Dosage Forms
400 mg and 600 mg tablets for oral administration
Omnizole
Indication
For the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening.
Omnizole
Pharmacology
Tocainide is a primary amine analog of lidocaine with antiarrhythmic properties useful in the treatment of ventricular arrhythmias. Tocainide, like lidocaine, produces dose dependent decreases in sodium and potassium conductance, thereby decreasing the excitability of myocardial cells. In experimental animal models, the dose-related depression of sodium current is more pronounced in ischemic tissue than in normal tissue. Tocainide is a Class I antiarrhythmic compound with electrophysiologic properties in man similar to those of lidocaine, but dissimilar from quinidine, procainamide, and disopyramide.
Omnizole
Absorption
Following oral administration, the bioavailability approaches 100 percent, and is unaffected by food.
Omnizole
side effects and Toxicity
The oral LD50 of tocainide was calculated to be about 800 mg/kg in mice, 1000 mg/kg in rats, and 230 mg/kg in guinea pigs; deaths were usually preceded by convulsions.
Omnizole
Patient Information
Omnizole
Organisms Affected
Humans and other mammals